The business of Science LLC advises existing and startup businesses on integrating business people with science people to run a profitable state of the art laboratories.  Bringing new science from the lab bench to the patient’s bedside.

The business of Science Consulting LLC

can help you create strategic business opportunities

This is a time of unchartered territory for laboratories as they find themselves unacquainted with the advanced ‘omic’ platforms, bioinformatic measurement requirements, along with the cutting-edge data analysis methods necessary to interpret these measurements.
We specialize in helping clients, ranging from medium-sized businesses to large multinational corporations, solve complex business and transaction issues.
As professionals in Life Sciences and Business Biomedical we help clients understand, analyze, and respond to various business opportunities and challenges.
A consumer-driven market for omic-wide tests is ushering a paradigm shift in medicine. Guesswork is being replaced with precision medicine, as biodata is leveraged to deliver a holistic view of individual patients. This shift is creating multifactorial health discoveries and financial opportunities for growth.

Are You Prepared for the Next Phase of Opportunities?

What is your vision for the future of patient care?

We are focused on Delivering

World-Class

‘Omics-Advanced Laboratories

Delivering a World-Class Omics-Advanced Laboratory

As science ushers in new breakthroughs, including next-generation sequencing, bioinformatics and ‘omics-wide testing labs are facing a paradigm shift as they navigate the development, launch, compliance and ongoing production of these discoveries..

Financial Opportunities

Great opportunities lie ahead for laboratories. These scientific advances hold the promise of providing higher quality healthcare, with a better understanding of how a disease is manifested along with therapies and promising treatments that are individualized by the patient.

Trust

One of the most crucial task for every lab is to be sensitive to ethical ramifications of the quality of their work and to ensure independent ethical oversight.

Significant Discoveries

When the progression of next-generation sequencing, bioinformatics and ‘omics have converged in such a way to create significant discoveries in health, disease, diagnostics, and treatment. The lab has the opportunity to support this research.

$710million

Strategic transition of a start-up to stock market company

over $30million

strategic savings

30%

Reduction in Cost Per Unit

50%

Expandability sample processing without adding FTEs

80%

Increased revenue

100%

Developed the world’s only Biorepository of Psychotropic samples

36

Journal Publications


17

Abstracts


15

Journal covers


1

Patent


6

Patents pending


22+

Labs inspected


9

Awards


72

Original assays created


The Business of Science Consulting can help you create strategic business opportunities.